Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...

Democratic senators are expressing alarm about planned budget reallocations at the Food and Drug Administration that they fear will threaten the nation’s food safety system. In a letter to FDA ...

Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to $550.00. Andrew Fein has given his Buy rating due ...

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Compiled by Jeremy Engle Is there a goal you’d like to pursue by doing ...

This leaflet answers some common questions about COSAMIDE 50. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

This leaflet answers some common questions about DAPA-TABS. It is not to be used in relation to any other product, which may also contain the same active ingredient. It does not contain all of the ...